NCT04369586View on ClinicalTrials.gov

A Phase I Clinical Trial of Meplazumab in Healthy Volunteer

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

April 25, 2020

Primary Completion Date

August 18, 2020

Study Completion Date

November 20, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

meplazumab for injection

single dose: 6 dose level, multiple dose: 0.3mg/kg/dose

DRUG

Placebo

placebo

Trial Locations (1)

710032

Xijing Hospital of the Fourth Military Medical University, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT04369586 - A Phase I Clinical Trial of Meplazumab in Healthy Volunteer | Biotech Hunter | Biotech Hunter